Hydrophilic versus hydrophobic porogens for engineering of poly(lactide-co-glycolide) microparticles containing risedronate sodium

Pharmaceutical Development and Technology

Volumn 18, Issue 5, 2013, Pages 1078-1088

  Nasr, Maha ^a   Awad, Gehanne A S ^a   Mansour, Samar ^a   Shamy, Abdelhamid Al ^a   Mortada, Nahed D ^a  

^a African Union Organization St Abbassia   (Egypt)

Author keywords

Engineered; Microspheres; Porogen; Pulmonary; Risedronate

Indexed keywords

MICROSPHERE; POLYGLACTIN; RISEDRONIC ACID;

ARTICLE; CELL LINE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SAFETY; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; MODULATION; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

BETA-CYCLODEXTRINS; CELL LINE; CORN OIL; ETIDRONIC ACID; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROSPHERES; MINERAL OIL; PARTICLE SIZE; POLYGLACTIN 910; POROSITY;

EID: 84885668475     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2012.693507     Document Type: Article

References (39)

1. Ungaro F, d'Emmanuele di Villa Bianca R, Giovino C, Miro A, Sorrentino R, Quaglia F et al. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J Control Release 2009;135:25-34.
2. Zeng XM, Martin GP, Marriott C. The controlled delivery of drugs to the lung. Int J Pharm 1995;124:149-164.
3. Kwon MJ, Bae JH, Kim JJ, Na K, Lee ES. Long acting porous microparticle for pulmonary protein delivery. Int J Pharm 2007;333:5-9.
4. Yang Y, Bajaj N, Xu P, Ohn K, Tsifansky MD, Yeo Y. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials 2009;30:1947-1953.
5. Kim H, Park H, Lee J, Kim TH, Lee ES, Oh KT et al. Highly porous large poly(lactic-co-glycolic acid) microspheres adsorbed with palmityl-acylated exendin-4 as a long-acting inhalation system for treating diabetes. Biomaterials 2011;32:1685-1693.
6. Pistel KF, Kissel T. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. J Microencapsul 2000;17:467-483.
7. Ungaro F, De Rosa G, Miro A, Quaglia F, La Rotonda MI. Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs. Eur J Pharm Sci 2006;28:423-432.
8. Ungaro F, Giovino C, Coletta C, Sorrentino R, Miro A, Quaglia F. Engineering gas-foamed large porous particles for efcient local delivery of macromolecules to the lung. Eur J Pharm Sci 2010;41:60-70.
9. Nasr M, Awad GA, Mansour S, Taha I, Al Shamy A, Mortada ND. Diferent modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. Eur J Pharm Biopharm 2011;79:601-611.
10. Lee J, Oh YJ, Lee SK, Lee KY. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery. J Control Release 2010;146:61-67.
11. Arnold MM, Gorman EM, Schieber LJ, Munson EJ, Berkland C. NanoCipro encapsulation in monodisperse large porous PLGA microparticles. J Control Release 2007;121:100-109.
12. Nasr M, Awad GA, Mansour S, Al Shamy A, Mortada ND. A reliable predictive factorial model for entrapment optimization of a sodium bisphosphonate into biodegradable microspheres. J Pharm Sci 2011;100:612-621.
13. Rawat A, Majumder QH, Ahsan F. Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation. J Control Release 2008;128:224-232.
14. Hou X, Wang X, Gao B, Yang J. Preparation and characterization of porous polysucrose microspheres. Carb Pol 2008;72:248-254.
15. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent difusion method. Eur J Pharm Biopharm 2003;55:297-304.
16. Vanbever R, Mintzes JD, Wang J, Nice J, Chen D, Batycky R et al. Formulation and physical characterization of large porous particles for inhalation. Pharm Res 1999;16:1735-1742.
17. Vay K, Scheler S, Friess W. New insights into the pore structure of poly(D, L-lactide-co-glycolide) microspheres. Int J Pharm 2010;402:20-26.
18. Bahl Y, Sah H. Dynamic changes in size distribution of emulsion droplets during ethyl acetate-based microencapsulation process. AAPS PharmSciTech 2000;1:E5.
19. Cook RO, Pannu RK, Kellaway IW. Novel sustained release microspheres for pulmonary drug delivery. J Control Release 2005;104:79-90.
20. Sivadas N, O'Rourke D, Tobin A, Buckley V, Ramtoola Z, Kelly JG et al. A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. Int J Pharm 2008;358:159-167.
21. Manca ML, Mourtas S, Dracopoulos V, Fadda AM, Antimisiaris SG. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization. Colloids Surf B Biointerfaces 2008;62:220-231.
22. Taki M, Marriott C, Zeng XM, Martin GP. Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactors. Int J Pharm 2010;388:40-51.
23. El-Sherbiny IM, Smyth HD. Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery: (I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres. Int J Pharm 2010;395:132-141.
24. Nafea EH, El-Massik MA, El-Khordagui LK, Marei MK, Khalafallah NM. Alendronate PLGA microspheres with high loading efciency for dental applications. J Microencapsul 2007;24:525-538.
25. Zannou EA, Streng WH, Stella VJ. Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins. Pharm Res 2001;18:1226-1231.
26. Higuti IH, Anunciacao Da Silva P, Papp J, Okiyama VM, Alves de Andrade E, Marcondes A, Nascimento AJ. Colorimetric determination of α and β-cyclodextrins and studies on optimization of CGTase production from B. frmus using factorial designs. Braz Arch Biol Technol 2004;47:837-841.
27. Bibby DC, Davies NM, Tucker IG. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm 2000;197:1-11.
28. Trapani G, Lopedota A, Boghetich G, Latrofa A, Franco M, Sanna E et al. Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-β-cyclodextrin. Int J Pharm 2003;268:47-57.
29. Tamber H, Johansen P, Merkle HP, Gander B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 2005;57:357-376.
30. Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J Control Release 2002;79:29-40.
31. Crotts G, Park TG. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J Control Rel 1995;35:91-105.
32. Mohamed F, van der Walle CF. PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNA. Int J Pharm 2006;311:97-107.
33. Chan HK, Chew NY. Novel alternative methods for the delivery of drugs for the treatment of asthma. Adv Drug Deliv Rev 2003;55:793-805.
34. Lester C, Lubey G, Dicks M, Andol G, Vaughn D, Cambron RT et al. Dehydration of risedronate hemi-pentahydrate: analytical and physical characterization. J Pharm Sci 2006;95:2631-2644.
35. Redman-Furey NL, Collins WJ. Termoanalytical characterization of the hydration states of risedronate. AAPS PharmSci 2003;5:S1.
36. Nguyen TN, Kim KJ. Kinetic study on hemipenta hydrate risedronate monosodium in batch crystallization by cooling mode. Int J Pharm 2008;364:1-8.
37. Chow AH, Tong HH, Chattopadhyay P, Shekunov BY. Particle engineering for pulmonary drug delivery. Pharm Res 2007;24:411-437.
38. Forbes B, Ehrhardt C. Human respiratory epithelial cell culture for drug delivery applications. Eur J Pharm Biopharm 2005;60:193-205.
39. Katsumi H, Nakatani M, Sano J, Abe M, Kusamori K, Kurihara M et al. Absorption and safety of alendronate, a nitrogen-containing bisphosphonate, after intrapulmonary administration in rats. Int J Pharm 2010;400:124-130.